Trials / Completed
CompletedNCT01746485
Three Times Daily Dosing of UT-15C
A PK Evaluation of Three Times Daily Dosing of UT-15C SR Tablets in Healthy Subjects
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 19 (actual)
- Sponsor
- United Therapeutics · Industry
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Accepted
Summary
To evaluate the pharmacokinetics of three-times daily dosing of UT-15C in healthy volunteers
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | UT-15C |
Timeline
- Start date
- 2012-07-01
- Primary completion
- 2012-07-01
- Completion
- 2012-07-01
- First posted
- 2012-12-11
- Last updated
- 2012-12-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01746485. Inclusion in this directory is not an endorsement.